Abstract
Objective
The aim of this study was to estimate the incidence of anaphylaxis in pregnancy and describe the management and outcomes in the UK.
Design
A population-based descriptive study using the UK Obstetric Surveillance System (UKOSS).
Setting
All consultant-led maternity units in the UK.
Population
All pregnant women who had anaphylaxis between 1 October 2012 and 30 September 2015. Anaphylaxis was defined as a severe, life-threatening generalised or systemic hypersensitivity reaction.
Methods
Prospective case notification using UKOSS.
Main outcome measures
Maternal mortality, severe maternal morbidity, neonatal mortality and severe neonatal morbidity.
Results
There were 37 confirmed cases of anaphylaxis in pregnancy, giving an estimated incidence of 1.6 (95% CI: 1.1–2.2) per 100 000 maternities. Four cases of anaphylaxis were in women with known penicillin allergies: two received co-amoxiclav and two cephalosporins. Twelve women had anaphylaxis following prophylactic use of antibiotics at the time of a caesarean delivery. Prophylactic use of antibiotics for Group B streptococcal infection accounted for anaphylaxis in one woman. Two women died (5%), 14 (38%) women were admitted to intensive care and seven women (19%) had one or more additional severe maternal morbidities, which included three haemorrhagic events, two cardiac arrests, one thrombotic event and one pneumonia. No infants died; however, in those infants whose mother had anaphylaxis before delivery (n = 18) there were seven (41%) neonatal intensive care unit admissions, three preterm births and one baby was cooled for neonatal encephalopathy.
Conclusions
Anaphylaxis is a rare severe complication of pregnancy and frequently the result of a reaction to antibiotic administration. This study highlights the seriousness of the outcomes of this condition for the mother. The low incidence is reassuring given the large proportion of the pregnant population that receive prophylactic antibiotics during delivery.
The aim of this study was to estimate the incidence of anaphylaxis in pregnancy and describe the management and outcomes in the UK.
Design
A population-based descriptive study using the UK Obstetric Surveillance System (UKOSS).
Setting
All consultant-led maternity units in the UK.
Population
All pregnant women who had anaphylaxis between 1 October 2012 and 30 September 2015. Anaphylaxis was defined as a severe, life-threatening generalised or systemic hypersensitivity reaction.
Methods
Prospective case notification using UKOSS.
Main outcome measures
Maternal mortality, severe maternal morbidity, neonatal mortality and severe neonatal morbidity.
Results
There were 37 confirmed cases of anaphylaxis in pregnancy, giving an estimated incidence of 1.6 (95% CI: 1.1–2.2) per 100 000 maternities. Four cases of anaphylaxis were in women with known penicillin allergies: two received co-amoxiclav and two cephalosporins. Twelve women had anaphylaxis following prophylactic use of antibiotics at the time of a caesarean delivery. Prophylactic use of antibiotics for Group B streptococcal infection accounted for anaphylaxis in one woman. Two women died (5%), 14 (38%) women were admitted to intensive care and seven women (19%) had one or more additional severe maternal morbidities, which included three haemorrhagic events, two cardiac arrests, one thrombotic event and one pneumonia. No infants died; however, in those infants whose mother had anaphylaxis before delivery (n = 18) there were seven (41%) neonatal intensive care unit admissions, three preterm births and one baby was cooled for neonatal encephalopathy.
Conclusions
Anaphylaxis is a rare severe complication of pregnancy and frequently the result of a reaction to antibiotic administration. This study highlights the seriousness of the outcomes of this condition for the mother. The low incidence is reassuring given the large proportion of the pregnant population that receive prophylactic antibiotics during delivery.
| Original language | English |
|---|---|
| Pages (from-to) | 965-971 |
| Number of pages | 7 |
| Journal | BJOG: An International Journal of Obstetrics and Gynaecology |
| Volume | 125 |
| Issue number | 8 |
| Early online date | 4 Jan 2018 |
| DOIs | |
| Publication status | Published - 2018 |
Bibliographical note
FundingThis paper reports on an independent study which is part-funded by the Policy Research Programme in the Department of Health. MK is funded by an NIHR Research Professorship. SM is funded by the Nuffield Department of Population Health and Medical Research Council (MRC) training grant MR/K501256/1. The views expressed in this publication are those of the author (s) and not necessarily those of the MRC, the NIHR or the Department of Health. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the article.
Acknowledgements
Thanks to Dr Manisha Nair for her advice.
Keywords
- anaphylaxis in pregnancy
- causal agents
- management
- outcomes
Access to Document
- McCall_etal_BJOG_The_Incidence_Characteristics_VoR
This is an open access article under the terms of the Creative Commons Attribution License, https://creativecommons.org/licenses/by/4.0/ which permits use, distribution and reproduction in any medium, provided the original work is properly.